Prognostic relevance of 46 clinical, "classical" laboratory and oncological parameters in patients with advanced non-small cell lung cancer.

被引：0
|
作者：
Holden-rieder, S
von Pawel, J
Heinemann, V
Raith, H
Feldmann, K
Stenman, UH
Nagel, D
Stieber, P
机构：
[1] Univ Munich, Klinikum Grosshadern, Inst Clin Chem, D-8000 Munich, Germany
[2] Asklepios Hosp, Gauting, Germany
[3] Univ Munich, Klinikum Grosshadern, Med Clin 2, D-8000 Munich, Germany
[4] Univ Helsinki, Cent Hosp, Helsinki, Finland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：669S / 669S
页数：1
相关论文
共 50 条
  • [1] Prognostic relevance of 60 clinical factors, "classical" laboratory parameters and tumor markers in patients with advanced non-small cell lung cancer
    Holdenrieder, S
    von Pawel, J
    Raith, H
    Feldmann, K
    Stenman, U
    Nagel, D
    Stieber, P
    LUNG CANCER, 2005, 49 : S248 - S248
  • [2] Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implications
    Scheffler, Matthias
    Wiesweg, Marcel
    Michels, Sebastian
    Nogova, Lucia
    Kron, Anna
    Herold, Thomas
    Scheel, Andreas H.
    Metzenmacher, Martin
    Eberhardt, Wilfried E.
    Reis, Henning
    Fassunke, Jana
    Darwiche, Kaid
    Aigner, Clemens
    Schaufler, Diana
    Riedel, Richard
    Fischer, Rieke
    Koleczko, Sophia
    Schildhaus, Hans-Ulrich
    Merkelbach-Bruse, Sabine
    Schmid, Kurt W.
    Buettner, Reinhard
    Wolf, Juergen
    Schuler, Martin
    LUNG CANCER, 2022, 168 : 10 - 20
  • [3] Prognostic relevance of 56 clinical factors, "classical" laboratory parameters and tumor markers in patients with small cell lung cancer
    Holdenrieder, S
    von Pawel, J
    Raith, H
    Feldmann, K
    Stenman, U
    Nagel, D
    Stieber, P
    LUNG CANCER, 2005, 49 : S321 - S321
  • [4] A Laboratory Prognostic Index Model for Patients with Advanced Non-Small Cell Lung Cancer
    Ulas, Arife
    Turkoz, Fatma Paksoy
    Silay, Kamile
    Tokluoglu, Saadet
    Avci, Nilufer
    Oksuzoglu, Berna
    Alkis, Necati
    PLOS ONE, 2014, 9 (12):
  • [5] Advanced non-small cell lung cancer.
    Edelman M.J.
    Khanwani S.L.
    Current Treatment Options in Oncology, 2001, 2 (1) : 51 - 62
  • [6] Minority patients in clinical trials (CT) for advanced non-small cell lung cancer.
    Obasaju, CK
    Catalano, RB
    Marinucci, DM
    Bloss, JD
    Taylor, L
    Monberg, MJ
    Comis, RL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 658S - 658S
  • [7] Clinical Prognostic Model for Older Patients with Advanced Non-Small Cell Lung Cancer
    Ganti, A. K.
    Wang, X.
    Stinchcombe, T.
    Wang, Y.
    Kelly, K.
    Paulus, R.
    Bradley, J.
    Ramalingam, S.
    Cohen, H.
    Vokes, E.
    Pang, H.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1878 - S1879
  • [8] Clinical prognostic model for older patients with advanced non-small cell lung cancer
    Ganti, Apar Kishor
    Wang, Xiaofei
    Stinchcombe, Thomas E.
    Wang, Yinpeng
    Bradley, Jeffrey
    Cohen, Harvey J.
    Kelly, Karen
    Paulus, Rebecca
    Ramalingam, Suresh S.
    Vokes, Everett E.
    Pang, Herbert
    JOURNAL OF GERIATRIC ONCOLOGY, 2019, 10 (04) : 555 - 559
  • [9] Clinical relevance of intratumoural immune cell composition in non-small cell lung cancer.
    Li, Xuetao
    Zhang, Jia-Tao
    Su, Jian
    Yang, Jinji
    Zhong, Wenzhao
    Zhang, Xuchao
    Wu, Yi-Long
    Hou, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Circadian function of patients with advanced non-small cell lung cancer.
    Levin, RD
    Grutsch, JF
    Hrushesky, WJM
    Quiton, J
    Quinn, K
    Daehler, M
    Lis, CG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 693S - 693S
12345